CBS Lunchtime Webinar on Thursday, April 10th - Dr. Darcy Wagner
0 comments
by Patricia Comeau
Dear CBS members, Greetings The Montreal Student Chapter of the Canadian Biomaterials Society is thrilled to invite you to a CBS Lunchtime webinar series talk and a lab tour on April 10th This event will feature an online presentation by Professor Darcy Wagner from McGill University at noon and an in-person lab tour starting at 4 30pm meet at RI-MUHC, Bloc E Atrium ...
A special CBS2025 opportunity for ECR faculty members!
0 comments
by Lindsay Fitzpatrick
Calling all ECR Faculty Members for Keynote Presentation Opportunities Dear CBS Members, A feature of CBS2025 will be presentations from current Early Career Researcher ECR faculty member highlighting their expertise and new research...
CBS2025 Final Abstract Submission Deadline Extension
0 comments
by
CBS2025 abstract submission deadline is extended until February 7th We know it is a busy time of year and so we are happy to announce that the CBS 2025 abstract submission deadline for the 39th Annual Meeting of the Canadian Biomaterial Society has been extended until February 7th, 2025 please note that this will be the last extension The CBS2025 Organizing Committee invites you to submit your abstracts related to biomaterials research through the Oxford Abstracts submission portal...
Tissue engineering is an important field that has allowed for the engineering of functional tissues in vitro and subsequent transplantation in vivo as a clinical strategy...
Bone regeneration remains an important hurdle in the field of tissue regeneration. Direct delivery of growth factors GF has received great attention due to their promising preclinical and clinical results...
In recent years, the development of multiplexing assays collecting multiple endpoints from one single sample has increased in a number of fields including toxicology and drug development ...
Synthetic graft biomaterials have been explored as alternatives to autologous grafts with considerable success in large- 8 mm and medium-diameter arteries 6-8 mm ...
Lipid nanoparticles LNPs containing short infering RNA siRNA and messenger RNA mRNA have been clinically shown to be able to treat the root cause of genetic diseases and confer protection against infection as with Onpattro and the recent COVID-19 vaccines, respectively...
